Dyne’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Dyne is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases. Read more

Joshua Brumm's photo - President & CEO of Dyne

President & CEO

Joshua Brumm

CEO Approval Rating

90/100

Founded:

2017

Status:

PublicNASDAQDYN

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Avidity Biosciences is Dyne's biggest rival. Avidity Biosciences was founded in La Jolla, California} in 2012. Like Dyne, Avidity Biosciences also competes in the Biotechnology sector. Compared to Dyne, Avidity Biosciences generates $4.8B less revenue.

Audentes Therapeutics is Dyne's #2 rival. Audentes Therapeutics's headquarters is in San Francisco, California, and was founded in 2012. Like Dyne, Audentes Therapeutics also competes in the Biotechnology space. Audentes Therapeutics generates 0.13% of Dyne's revenue.

Sarepta is Dyne's #3 competitor. Sarepta was founded in 1980 in Cambridge, Massachusetts. Like Dyne, Sarepta also works within the Pharmaceuticals sector. Sarepta generates $4.3B less revenue than Dyne.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Keros a competitor of Dyne?

Quarterly and Annual Revenue

Coming soon for Dyne!

Annual Revenue

$4.8B

Dyne's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 562.2M.

Acquisitions

No recent acquisitions found related to Dyne

Dyne Funding History

$50M$398M

Since Dyne was founded in 2017, it has participated in 4 rounds of funding. In total Dyne has raised $398.0M. Dyne's last funding round was on Sep 2020 for a total of $233.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Sep 2020
$233M
-
Equity
Aug 2020
$115M
Equity
Mar 2020
--
Series A
Apr 2019
$50M

Total Funding: $398M

Since Dyne was founded in 2017, it has participated in 4 rounds of funding. In total Dyne has raised $398.0M. Dyne's last funding round was on Sep 2020 for a total of $233.0M

Investments

No recent investments found related to Dyne

Dyne News

September 18, 2020Bizjournals

Dyne raises $233M in 19th Mass. IPO this year

Amid a parade of upsized biotech IPOs this year, a Waltham company working on drugs to treat muscle d... See more »
September 18, 2020Xconomy

Dyne's Upsized IPO Brings In $233M for Muscle Disorders Drug R&D

Dyne Therapeutics, a company developing genetic medicines for rare muscular disorders, has raised $23... See more »
September 17, 2020Venture Capital Journal

VC-backed Dyne Therapeutics goes public

Dyne Therapeutics Inc, a muscle disease company, has raised about $233 million for its IPO after pric... See more »
September 17, 2020Benzinga

Dyne Therapeutics Announces Pricing of Initial Public Offering

WALTHAM, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a muscle dis... See more »
September 14, 2020Boston Citybizlist

Dyne Therapeutics Readies $175 Million IPO

August 26, 2020Xconomy

Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases

Not long ago, having early data about how an experimental drug worked in humans was expected of biote... See more »

Headquarters

830 Winter Street

Waltham, Massachusetts02451

781-786-8230

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Dyne is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases. Dyne was founded in 2017. Dyne's headquarters is located in Waltham, Massachusetts, USA 02451. It has raised 398.0M in 4 rounds. The l...

CEO

Dyne's President & CEO, Joshua Brumm, currently has an approval rating of 90%. Dyne's primary competitors are Avidity Biosciences, Audentes Therapeutics & Sarepta.

Website

dyne-tx.com

Frequently Asked Questions about Dyne

  1. When was Dyne founded?

    Dyne was founded in 2017
  2. Who is Dyne's CEO?

    Dyne's CEO is Joshua Brumm
  3. How much revenue does Dyne generate?

    Dyne generates $4.8B in revenue
  4. How much funding does Dyne have?

    Dyne has historically raised $398M in funding
  1. Where is Dyne's headquarters?

    Dyne's headquarters is in Waltham Massachusetts, USA
  2. How many employees does Dyne have?

    Dyne has 2,117 employees
  3. What sector does Dyne operate in?

    Dyne is in Biotechnology, Pharmaceuticals
  4. Who are Dyne's competitors?

    Dyne's top competitors are Avidity Biosciences, Audentes Therapeutics, Sarepta